| 7.8 |
23.3 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 5.4 |
38.1 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 4.5 |
13.4 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 4.3 |
17.0 |
GO:0086042 |
cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 4.2 |
12.6 |
GO:0030827 |
negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 3.9 |
11.6 |
GO:0016332 |
establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 3.5 |
10.5 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 3.4 |
10.3 |
GO:0035701 |
hematopoietic stem cell migration(GO:0035701) |
| 3.3 |
16.5 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 3.2 |
9.7 |
GO:1903423 |
positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
| 3.1 |
9.4 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 2.8 |
11.2 |
GO:1901204 |
regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) |
| 2.7 |
8.2 |
GO:1901731 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) positive regulation of platelet aggregation(GO:1901731) |
| 2.6 |
5.3 |
GO:1904457 |
positive regulation of neuronal action potential(GO:1904457) |
| 2.6 |
10.4 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 2.5 |
12.7 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 2.5 |
15.2 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 2.4 |
7.3 |
GO:0042323 |
negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 2.3 |
9.2 |
GO:0021586 |
pons maturation(GO:0021586) |
| 2.3 |
13.6 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 2.2 |
6.7 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 2.2 |
6.5 |
GO:0007210 |
serotonin receptor signaling pathway(GO:0007210) |
| 2.1 |
2.1 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 2.1 |
6.2 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 2.0 |
6.1 |
GO:1900369 |
negative regulation of RNA interference(GO:1900369) |
| 2.0 |
5.9 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 1.9 |
7.8 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 1.9 |
5.7 |
GO:0070428 |
regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
| 1.9 |
5.7 |
GO:0043379 |
memory T cell differentiation(GO:0043379) |
| 1.9 |
7.6 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 1.9 |
17.0 |
GO:0021894 |
cerebral cortex GABAergic interneuron development(GO:0021894) |
| 1.9 |
11.3 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 1.8 |
3.7 |
GO:0010808 |
positive regulation of synaptic vesicle priming(GO:0010808) |
| 1.8 |
20.1 |
GO:0010650 |
positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 1.8 |
5.3 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
| 1.8 |
5.3 |
GO:0017055 |
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 1.8 |
5.3 |
GO:0071873 |
response to norepinephrine(GO:0071873) |
| 1.7 |
3.5 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 1.7 |
6.9 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) |
| 1.7 |
10.0 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 1.7 |
5.0 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 1.6 |
6.5 |
GO:1901492 |
positive regulation of lymphangiogenesis(GO:1901492) |
| 1.6 |
9.6 |
GO:0021636 |
trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) |
| 1.6 |
1.6 |
GO:0042726 |
flavin-containing compound metabolic process(GO:0042726) |
| 1.6 |
4.8 |
GO:0060060 |
post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
| 1.6 |
6.3 |
GO:0046898 |
response to cycloheximide(GO:0046898) |
| 1.5 |
49.1 |
GO:0048488 |
synaptic vesicle endocytosis(GO:0048488) |
| 1.5 |
13.8 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 1.5 |
33.5 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 1.5 |
7.5 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 1.5 |
10.5 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 1.5 |
1.5 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 1.5 |
8.9 |
GO:2000664 |
positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
| 1.5 |
7.4 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 1.5 |
2.9 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 1.4 |
5.8 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 1.4 |
1.4 |
GO:1900272 |
negative regulation of long-term synaptic potentiation(GO:1900272) |
| 1.4 |
7.0 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 1.4 |
4.2 |
GO:0032765 |
positive regulation of mast cell cytokine production(GO:0032765) |
| 1.4 |
4.1 |
GO:0010958 |
regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) |
| 1.4 |
4.1 |
GO:0097401 |
synaptic vesicle lumen acidification(GO:0097401) |
| 1.3 |
4.0 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 1.3 |
4.0 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) negative regulation of hair follicle development(GO:0051799) |
| 1.3 |
5.2 |
GO:0010693 |
negative regulation of alkaline phosphatase activity(GO:0010693) |
| 1.3 |
3.9 |
GO:0010752 |
regulation of cGMP-mediated signaling(GO:0010752) |
| 1.3 |
5.2 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 1.3 |
10.2 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
| 1.3 |
1.3 |
GO:0072008 |
glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
| 1.2 |
8.7 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 1.2 |
1.2 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 1.2 |
3.7 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 1.2 |
3.7 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 1.2 |
3.7 |
GO:0035435 |
phosphate ion transmembrane transport(GO:0035435) |
| 1.2 |
3.7 |
GO:0060596 |
mammary placode formation(GO:0060596) |
| 1.2 |
4.9 |
GO:0018197 |
peptidyl-aspartic acid modification(GO:0018197) |
| 1.2 |
11.0 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 1.2 |
13.3 |
GO:1901250 |
regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
| 1.2 |
5.9 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 1.2 |
9.3 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 1.2 |
4.6 |
GO:0042364 |
water-soluble vitamin biosynthetic process(GO:0042364) |
| 1.2 |
7.0 |
GO:0061718 |
NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 1.2 |
5.8 |
GO:0009408 |
response to heat(GO:0009408) |
| 1.1 |
3.4 |
GO:0046959 |
habituation(GO:0046959) |
| 1.1 |
1.1 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 1.1 |
2.2 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 1.1 |
3.3 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 1.1 |
3.3 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 1.1 |
8.8 |
GO:0014832 |
urinary bladder smooth muscle contraction(GO:0014832) |
| 1.1 |
9.9 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 1.1 |
13.1 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 1.1 |
1.1 |
GO:2000546 |
positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 1.1 |
1.1 |
GO:0060160 |
negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 1.0 |
1.0 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 1.0 |
3.1 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 1.0 |
3.1 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 1.0 |
3.1 |
GO:1902109 |
negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 1.0 |
1.0 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 1.0 |
5.2 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) |
| 1.0 |
3.1 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 1.0 |
2.1 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) |
| 1.0 |
3.9 |
GO:0050913 |
sensory perception of bitter taste(GO:0050913) |
| 1.0 |
4.9 |
GO:0021814 |
cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) |
| 1.0 |
7.9 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 1.0 |
5.9 |
GO:0046103 |
inosine biosynthetic process(GO:0046103) |
| 1.0 |
20.5 |
GO:1900273 |
positive regulation of long-term synaptic potentiation(GO:1900273) |
| 1.0 |
11.7 |
GO:0061577 |
calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 1.0 |
7.8 |
GO:0010820 |
positive regulation of T cell chemotaxis(GO:0010820) |
| 1.0 |
13.6 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 1.0 |
2.9 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 1.0 |
1.9 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 1.0 |
15.4 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 0.9 |
1.8 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.9 |
0.9 |
GO:2000670 |
positive regulation of dendritic cell apoptotic process(GO:2000670) |
| 0.9 |
3.7 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.9 |
6.4 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
| 0.9 |
2.7 |
GO:0045869 |
negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
| 0.9 |
2.7 |
GO:0060066 |
oviduct development(GO:0060066) |
| 0.9 |
12.6 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.9 |
3.6 |
GO:0044330 |
canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.9 |
1.8 |
GO:1901841 |
regulation of high voltage-gated calcium channel activity(GO:1901841) |
| 0.9 |
1.8 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 0.9 |
3.5 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.9 |
4.4 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.9 |
2.6 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.9 |
1.8 |
GO:0060482 |
lobar bronchus development(GO:0060482) |
| 0.9 |
1.8 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.9 |
2.6 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
| 0.9 |
0.9 |
GO:0032632 |
interleukin-3 production(GO:0032632) |
| 0.9 |
0.9 |
GO:0090258 |
negative regulation of mitochondrial fission(GO:0090258) |
| 0.9 |
0.9 |
GO:0035799 |
ureter maturation(GO:0035799) |
| 0.8 |
4.2 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.8 |
2.5 |
GO:0009182 |
purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
| 0.8 |
1.7 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.8 |
5.8 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.8 |
3.3 |
GO:0045896 |
regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
| 0.8 |
5.7 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.8 |
2.4 |
GO:0032914 |
positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.8 |
2.4 |
GO:0032499 |
detection of peptidoglycan(GO:0032499) |
| 0.8 |
15.2 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.8 |
2.4 |
GO:0010511 |
regulation of phosphatidylinositol biosynthetic process(GO:0010511) negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 0.8 |
2.4 |
GO:1901894 |
regulation of calcium-transporting ATPase activity(GO:1901894) |
| 0.8 |
2.4 |
GO:0099624 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 0.8 |
1.6 |
GO:0061209 |
cell proliferation involved in mesonephros development(GO:0061209) mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
| 0.8 |
4.0 |
GO:0036115 |
fatty-acyl-CoA catabolic process(GO:0036115) |
| 0.8 |
9.5 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.8 |
3.9 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.8 |
3.9 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 0.8 |
3.1 |
GO:2000304 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.8 |
2.3 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.8 |
4.6 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.8 |
1.5 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.8 |
0.8 |
GO:0061418 |
regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
| 0.8 |
0.8 |
GO:0034140 |
negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
| 0.7 |
11.2 |
GO:0042492 |
gamma-delta T cell differentiation(GO:0042492) |
| 0.7 |
6.7 |
GO:0060665 |
regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
| 0.7 |
3.0 |
GO:0060591 |
chondroblast differentiation(GO:0060591) |
| 0.7 |
11.1 |
GO:0016082 |
synaptic vesicle priming(GO:0016082) |
| 0.7 |
5.2 |
GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.7 |
11.1 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.7 |
5.9 |
GO:0014850 |
response to muscle activity(GO:0014850) |
| 0.7 |
0.7 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
| 0.7 |
3.6 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.7 |
2.9 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.7 |
5.7 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.7 |
2.9 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.7 |
4.3 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.7 |
2.1 |
GO:0002538 |
arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
| 0.7 |
2.1 |
GO:2000851 |
positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
| 0.7 |
3.5 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.7 |
1.4 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.7 |
1.4 |
GO:0021859 |
pyramidal neuron differentiation(GO:0021859) |
| 0.7 |
5.6 |
GO:0017085 |
response to insecticide(GO:0017085) |
| 0.7 |
1.4 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 0.7 |
20.1 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.7 |
3.4 |
GO:0032423 |
regulation of mismatch repair(GO:0032423) |
| 0.7 |
2.8 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.7 |
5.5 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.7 |
7.5 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.7 |
2.7 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.7 |
2.0 |
GO:1902071 |
regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
| 0.7 |
0.7 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.7 |
4.0 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.7 |
2.0 |
GO:2000598 |
regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
| 0.7 |
2.6 |
GO:1901030 |
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
| 0.7 |
2.0 |
GO:0060912 |
cardiac cell fate specification(GO:0060912) |
| 0.7 |
3.3 |
GO:0060080 |
inhibitory postsynaptic potential(GO:0060080) |
| 0.7 |
6.5 |
GO:2001135 |
regulation of endocytic recycling(GO:2001135) |
| 0.7 |
1.3 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.7 |
2.6 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.6 |
3.9 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.6 |
4.5 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.6 |
1.9 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 0.6 |
2.6 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.6 |
3.2 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.6 |
10.8 |
GO:2000463 |
positive regulation of excitatory postsynaptic potential(GO:2000463) |
| 0.6 |
0.6 |
GO:0060535 |
trachea cartilage morphogenesis(GO:0060535) |
| 0.6 |
5.7 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.6 |
1.9 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.6 |
2.5 |
GO:0090336 |
positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.6 |
3.8 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.6 |
15.6 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.6 |
3.7 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.6 |
2.5 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.6 |
3.7 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.6 |
11.7 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.6 |
0.6 |
GO:1902036 |
regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.6 |
1.2 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.6 |
1.2 |
GO:0060648 |
mammary gland bud morphogenesis(GO:0060648) |
| 0.6 |
1.8 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.6 |
1.8 |
GO:0031038 |
myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
| 0.6 |
1.2 |
GO:0060467 |
negative regulation of fertilization(GO:0060467) |
| 0.6 |
1.8 |
GO:0044337 |
canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
| 0.6 |
0.6 |
GO:0010749 |
regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 0.6 |
4.1 |
GO:0045161 |
neuronal ion channel clustering(GO:0045161) |
| 0.6 |
2.9 |
GO:0072015 |
glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
| 0.6 |
4.1 |
GO:0061092 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.6 |
15.1 |
GO:0043496 |
regulation of protein homodimerization activity(GO:0043496) |
| 0.6 |
1.7 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.6 |
2.9 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.6 |
3.5 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.6 |
10.9 |
GO:0033198 |
response to ATP(GO:0033198) |
| 0.6 |
2.8 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.6 |
5.1 |
GO:0072583 |
clathrin-mediated endocytosis(GO:0072583) |
| 0.6 |
6.8 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.6 |
0.6 |
GO:0050847 |
progesterone receptor signaling pathway(GO:0050847) |
| 0.6 |
3.4 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.6 |
1.7 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.6 |
2.2 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.6 |
5.0 |
GO:0002536 |
respiratory burst involved in inflammatory response(GO:0002536) |
| 0.6 |
6.1 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.6 |
3.3 |
GO:0045346 |
regulation of MHC class II biosynthetic process(GO:0045346) |
| 0.6 |
6.1 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.6 |
3.3 |
GO:0086012 |
membrane depolarization during cardiac muscle cell action potential(GO:0086012) |
| 0.5 |
0.5 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.5 |
2.2 |
GO:0008627 |
intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
| 0.5 |
7.6 |
GO:0021540 |
corpus callosum morphogenesis(GO:0021540) |
| 0.5 |
2.2 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.5 |
5.9 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.5 |
2.2 |
GO:0055095 |
lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 0.5 |
3.2 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
| 0.5 |
1.1 |
GO:0010730 |
regulation of hydrogen peroxide metabolic process(GO:0010310) negative regulation of hydrogen peroxide metabolic process(GO:0010727) regulation of hydrogen peroxide biosynthetic process(GO:0010728) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.5 |
0.5 |
GO:1901252 |
regulation of intracellular transport of viral material(GO:1901252) |
| 0.5 |
0.5 |
GO:0060620 |
regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.5 |
1.6 |
GO:0006592 |
ornithine biosynthetic process(GO:0006592) |
| 0.5 |
0.5 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.5 |
1.0 |
GO:0006867 |
asparagine transport(GO:0006867) glutamine transport(GO:0006868) |
| 0.5 |
1.6 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.5 |
1.6 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.5 |
1.0 |
GO:0032513 |
negative regulation of protein phosphatase type 2B activity(GO:0032513) |
| 0.5 |
1.5 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.5 |
4.0 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.5 |
2.0 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.5 |
0.5 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.5 |
1.0 |
GO:2000501 |
natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 0.5 |
3.0 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.5 |
2.5 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.5 |
1.5 |
GO:0060334 |
regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.5 |
3.4 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.5 |
1.5 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.5 |
8.2 |
GO:0071378 |
growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.5 |
2.4 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.5 |
1.9 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.5 |
7.2 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.5 |
0.9 |
GO:0002606 |
dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
| 0.5 |
1.4 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.5 |
0.5 |
GO:0071220 |
response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
| 0.5 |
3.7 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.5 |
1.4 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.5 |
1.8 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.5 |
1.4 |
GO:0003308 |
negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
| 0.5 |
2.3 |
GO:0044154 |
histone H3-K14 acetylation(GO:0044154) |
| 0.5 |
2.7 |
GO:0030432 |
peristalsis(GO:0030432) |
| 0.5 |
1.8 |
GO:0051798 |
positive regulation of hair follicle development(GO:0051798) |
| 0.4 |
0.9 |
GO:2000195 |
negative regulation of female gonad development(GO:2000195) |
| 0.4 |
3.6 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.4 |
1.8 |
GO:0046880 |
regulation of follicle-stimulating hormone secretion(GO:0046880) follicle-stimulating hormone secretion(GO:0046884) |
| 0.4 |
4.0 |
GO:0051901 |
positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.4 |
1.3 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.4 |
3.5 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.4 |
1.3 |
GO:0009193 |
pyrimidine ribonucleoside diphosphate metabolic process(GO:0009193) UDP metabolic process(GO:0046048) |
| 0.4 |
4.0 |
GO:0050849 |
negative regulation of calcium-mediated signaling(GO:0050849) |
| 0.4 |
2.2 |
GO:0010991 |
regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.4 |
1.3 |
GO:0042541 |
hemoglobin biosynthetic process(GO:0042541) |
| 0.4 |
3.0 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.4 |
1.3 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.4 |
2.1 |
GO:0070535 |
histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.4 |
3.9 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.4 |
1.7 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.4 |
6.8 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.4 |
0.8 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.4 |
1.7 |
GO:0006848 |
pyruvate transport(GO:0006848) |
| 0.4 |
0.8 |
GO:1900149 |
positive regulation of Schwann cell migration(GO:1900149) |
| 0.4 |
3.8 |
GO:0098904 |
regulation of AV node cell action potential(GO:0098904) |
| 0.4 |
1.3 |
GO:1901339 |
regulation of store-operated calcium channel activity(GO:1901339) |
| 0.4 |
0.8 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.4 |
2.9 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.4 |
1.7 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.4 |
6.7 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.4 |
5.8 |
GO:0046855 |
phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 0.4 |
12.8 |
GO:0006198 |
cAMP catabolic process(GO:0006198) |
| 0.4 |
0.8 |
GO:0061724 |
lipophagy(GO:0061724) |
| 0.4 |
4.1 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.4 |
2.4 |
GO:0009098 |
branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.4 |
1.2 |
GO:0032364 |
oxygen homeostasis(GO:0032364) |
| 0.4 |
4.0 |
GO:0032703 |
negative regulation of interleukin-2 production(GO:0032703) |
| 0.4 |
0.4 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.4 |
0.4 |
GO:0016479 |
negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.4 |
14.5 |
GO:0045022 |
early endosome to late endosome transport(GO:0045022) |
| 0.4 |
0.8 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.4 |
4.4 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.4 |
2.8 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.4 |
1.2 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.4 |
2.0 |
GO:0040038 |
polar body extrusion after meiotic divisions(GO:0040038) |
| 0.4 |
0.4 |
GO:0042713 |
sperm ejaculation(GO:0042713) |
| 0.4 |
0.4 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.4 |
6.3 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.4 |
28.6 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.4 |
1.2 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.4 |
3.5 |
GO:0048070 |
regulation of developmental pigmentation(GO:0048070) |
| 0.4 |
0.8 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.4 |
4.7 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.4 |
1.9 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.4 |
1.1 |
GO:0086013 |
membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
| 0.4 |
9.5 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.4 |
1.1 |
GO:0003345 |
proepicardium cell migration involved in pericardium morphogenesis(GO:0003345) |
| 0.4 |
2.6 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
| 0.4 |
2.3 |
GO:0061668 |
mitochondrial ribosome assembly(GO:0061668) |
| 0.4 |
0.7 |
GO:0007262 |
STAT protein import into nucleus(GO:0007262) |
| 0.4 |
4.1 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.4 |
1.9 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.4 |
1.5 |
GO:2001181 |
positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.4 |
1.9 |
GO:0032298 |
positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
| 0.4 |
2.2 |
GO:0043144 |
snoRNA processing(GO:0043144) |
| 0.4 |
1.1 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.4 |
1.1 |
GO:0070488 |
neutrophil aggregation(GO:0070488) |
| 0.4 |
2.2 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.4 |
0.7 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.4 |
3.3 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.4 |
0.4 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
| 0.4 |
1.4 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.4 |
1.4 |
GO:0061622 |
glycolytic process through glucose-1-phosphate(GO:0061622) |
| 0.4 |
2.5 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.4 |
2.5 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.4 |
0.7 |
GO:0051703 |
social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.4 |
4.6 |
GO:0022401 |
desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.4 |
0.7 |
GO:0051342 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.4 |
0.7 |
GO:0046098 |
guanine metabolic process(GO:0046098) |
| 0.3 |
4.5 |
GO:0051205 |
protein insertion into membrane(GO:0051205) |
| 0.3 |
0.3 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.3 |
11.3 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.3 |
1.7 |
GO:0046549 |
retinal cone cell development(GO:0046549) |
| 0.3 |
3.8 |
GO:0030157 |
pancreatic juice secretion(GO:0030157) |
| 0.3 |
0.7 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.3 |
1.0 |
GO:0046013 |
T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.3 |
0.3 |
GO:0097168 |
mesenchymal stem cell proliferation(GO:0097168) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.3 |
1.0 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.3 |
1.0 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.3 |
0.7 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
| 0.3 |
1.3 |
GO:0015786 |
UDP-glucose transport(GO:0015786) |
| 0.3 |
4.9 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.3 |
8.1 |
GO:0010466 |
negative regulation of peptidase activity(GO:0010466) |
| 0.3 |
8.5 |
GO:0061098 |
positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.3 |
1.0 |
GO:0030300 |
regulation of intestinal cholesterol absorption(GO:0030300) |
| 0.3 |
1.6 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.3 |
1.9 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.3 |
7.4 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.3 |
1.0 |
GO:0000965 |
mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.3 |
1.6 |
GO:0072429 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.3 |
1.0 |
GO:0075136 |
response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
| 0.3 |
1.6 |
GO:0045657 |
positive regulation of monocyte differentiation(GO:0045657) |
| 0.3 |
2.2 |
GO:0072017 |
distal tubule development(GO:0072017) |
| 0.3 |
1.3 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.3 |
0.9 |
GO:0006578 |
amino-acid betaine biosynthetic process(GO:0006578) |
| 0.3 |
0.3 |
GO:0030397 |
membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
| 0.3 |
5.3 |
GO:0042220 |
response to cocaine(GO:0042220) |
| 0.3 |
1.2 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 0.3 |
2.2 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.3 |
0.3 |
GO:0090335 |
regulation of brown fat cell differentiation(GO:0090335) |
| 0.3 |
1.2 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.3 |
1.5 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.3 |
1.2 |
GO:0071372 |
cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.3 |
2.1 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.3 |
8.6 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.3 |
1.8 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.3 |
1.5 |
GO:0048311 |
mitochondrion distribution(GO:0048311) |
| 0.3 |
0.9 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.3 |
1.5 |
GO:2000252 |
negative regulation of feeding behavior(GO:2000252) |
| 0.3 |
2.4 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.3 |
0.3 |
GO:0042776 |
mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.3 |
0.6 |
GO:0070944 |
neutrophil mediated killing of bacterium(GO:0070944) |
| 0.3 |
2.1 |
GO:0033603 |
positive regulation of dopamine secretion(GO:0033603) |
| 0.3 |
0.6 |
GO:0097066 |
response to thyroid hormone(GO:0097066) |
| 0.3 |
2.1 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.3 |
2.7 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.3 |
0.9 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
| 0.3 |
1.2 |
GO:2000110 |
protein sialylation(GO:1990743) negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.3 |
2.4 |
GO:1901385 |
regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.3 |
1.8 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.3 |
0.6 |
GO:0021933 |
radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.3 |
1.7 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.3 |
0.6 |
GO:0061526 |
acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) musculoskeletal movement, spinal reflex action(GO:0050883) acetylcholine secretion(GO:0061526) |
| 0.3 |
1.4 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.3 |
7.1 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.3 |
1.7 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.3 |
0.9 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.3 |
0.3 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.3 |
3.1 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.3 |
0.8 |
GO:0035509 |
negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
| 0.3 |
0.8 |
GO:0044650 |
virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
| 0.3 |
1.4 |
GO:0015692 |
vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) |
| 0.3 |
0.3 |
GO:1901228 |
positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 0.3 |
3.3 |
GO:1902803 |
regulation of synaptic vesicle transport(GO:1902803) |
| 0.3 |
3.3 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.3 |
0.8 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
| 0.3 |
1.4 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.3 |
3.2 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.3 |
0.8 |
GO:0060768 |
regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
| 0.3 |
0.8 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.3 |
2.4 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.3 |
3.0 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.3 |
1.9 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.3 |
1.1 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.3 |
0.8 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 0.3 |
0.8 |
GO:0015919 |
peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 0.3 |
1.3 |
GO:0006144 |
purine nucleobase metabolic process(GO:0006144) |
| 0.3 |
3.7 |
GO:0045838 |
positive regulation of membrane potential(GO:0045838) |
| 0.3 |
0.5 |
GO:0047484 |
regulation of response to osmotic stress(GO:0047484) |
| 0.3 |
0.8 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.3 |
0.3 |
GO:0006404 |
RNA import into nucleus(GO:0006404) |
| 0.3 |
0.5 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.3 |
2.0 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.3 |
0.3 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.3 |
1.8 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.3 |
5.1 |
GO:0001782 |
B cell homeostasis(GO:0001782) |
| 0.3 |
0.5 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 0.3 |
0.8 |
GO:0051542 |
elastin biosynthetic process(GO:0051542) |
| 0.3 |
4.3 |
GO:0007616 |
long-term memory(GO:0007616) |
| 0.2 |
0.2 |
GO:0070427 |
nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 0.2 |
3.7 |
GO:0045214 |
sarcomere organization(GO:0045214) |
| 0.2 |
1.2 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.2 |
4.9 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.2 |
0.5 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.2 |
1.2 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.2 |
1.7 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.2 |
1.5 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.2 |
1.0 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.2 |
1.0 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.2 |
1.9 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.2 |
1.2 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.2 |
0.2 |
GO:0021800 |
cerebral cortex tangential migration(GO:0021800) |
| 0.2 |
0.7 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.2 |
1.7 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.2 |
9.1 |
GO:1902284 |
axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
| 0.2 |
1.2 |
GO:0008655 |
pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.2 |
1.4 |
GO:0044068 |
modulation by symbiont of host cellular process(GO:0044068) |
| 0.2 |
1.9 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.2 |
1.4 |
GO:0021678 |
third ventricle development(GO:0021678) |
| 0.2 |
7.0 |
GO:0021680 |
cerebellar Purkinje cell layer development(GO:0021680) |
| 0.2 |
2.3 |
GO:1901070 |
guanosine-containing compound biosynthetic process(GO:1901070) |
| 0.2 |
2.3 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.2 |
0.2 |
GO:0071474 |
cellular hyperosmotic response(GO:0071474) |
| 0.2 |
0.2 |
GO:0097503 |
sialylation(GO:0097503) |
| 0.2 |
0.5 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.2 |
0.2 |
GO:0002553 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.2 |
0.7 |
GO:0034351 |
regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.2 |
0.9 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.2 |
0.2 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.2 |
0.5 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.2 |
0.7 |
GO:1904526 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
| 0.2 |
2.3 |
GO:1904152 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.2 |
2.5 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.2 |
1.8 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.2 |
1.1 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.2 |
0.4 |
GO:1901838 |
positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.2 |
0.9 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.2 |
0.7 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
| 0.2 |
0.9 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.2 |
0.6 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.2 |
1.5 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.2 |
0.4 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.2 |
1.1 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.2 |
3.9 |
GO:0017158 |
regulation of calcium ion-dependent exocytosis(GO:0017158) |
| 0.2 |
0.6 |
GO:0071545 |
inositol phosphate catabolic process(GO:0071545) |
| 0.2 |
0.2 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
| 0.2 |
1.7 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.2 |
0.6 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.2 |
0.2 |
GO:0048294 |
negative regulation of isotype switching(GO:0045829) negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.2 |
0.8 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.2 |
2.1 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.2 |
7.3 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.2 |
0.6 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
| 0.2 |
0.4 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.2 |
3.1 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.2 |
4.3 |
GO:0097576 |
vacuole fusion(GO:0097576) |
| 0.2 |
0.4 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.2 |
0.4 |
GO:0006407 |
rRNA export from nucleus(GO:0006407) |
| 0.2 |
1.0 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 0.2 |
2.6 |
GO:0051352 |
negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.2 |
0.8 |
GO:0036315 |
cellular response to sterol(GO:0036315) |
| 0.2 |
0.2 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.2 |
0.8 |
GO:0060709 |
glycogen cell differentiation involved in embryonic placenta development(GO:0060709) |
| 0.2 |
3.4 |
GO:0035640 |
exploration behavior(GO:0035640) |
| 0.2 |
0.8 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
| 0.2 |
2.0 |
GO:0060510 |
Type II pneumocyte differentiation(GO:0060510) |
| 0.2 |
4.1 |
GO:1904030 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.2 |
0.8 |
GO:0007603 |
phototransduction, visible light(GO:0007603) |
| 0.2 |
1.8 |
GO:0048845 |
venous blood vessel morphogenesis(GO:0048845) |
| 0.2 |
0.4 |
GO:0048278 |
vesicle docking(GO:0048278) |
| 0.2 |
0.8 |
GO:0018158 |
protein oxidation(GO:0018158) |
| 0.2 |
1.2 |
GO:0033006 |
regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.2 |
1.7 |
GO:0030049 |
muscle filament sliding(GO:0030049) |
| 0.2 |
3.5 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.2 |
1.5 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.2 |
0.6 |
GO:0042560 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.2 |
0.6 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.2 |
1.3 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.2 |
1.3 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.2 |
0.6 |
GO:0045351 |
type I interferon biosynthetic process(GO:0045351) |
| 0.2 |
1.3 |
GO:0035767 |
endothelial cell chemotaxis(GO:0035767) |
| 0.2 |
1.7 |
GO:0034122 |
negative regulation of toll-like receptor signaling pathway(GO:0034122) |
| 0.2 |
0.6 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.2 |
0.6 |
GO:0019405 |
alditol catabolic process(GO:0019405) glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.2 |
0.6 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.2 |
1.3 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.2 |
4.9 |
GO:0018279 |
peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.2 |
0.4 |
GO:0050951 |
sensory perception of temperature stimulus(GO:0050951) |
| 0.2 |
1.3 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.2 |
0.2 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.2 |
0.2 |
GO:0015870 |
acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
| 0.2 |
0.7 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.2 |
0.7 |
GO:0032469 |
endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.2 |
0.5 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.2 |
0.9 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.2 |
0.7 |
GO:0065001 |
negative regulation of histone H3-K36 methylation(GO:0000415) specification of axis polarity(GO:0065001) |
| 0.2 |
2.6 |
GO:0006047 |
UDP-N-acetylglucosamine metabolic process(GO:0006047) |
| 0.2 |
3.2 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.2 |
0.5 |
GO:0032225 |
regulation of synaptic transmission, dopaminergic(GO:0032225) |
| 0.2 |
0.5 |
GO:0071549 |
response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
| 0.2 |
1.2 |
GO:0035898 |
parathyroid hormone secretion(GO:0035898) |
| 0.2 |
1.3 |
GO:0071218 |
cellular response to misfolded protein(GO:0071218) |
| 0.2 |
0.8 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.2 |
0.5 |
GO:0048241 |
epinephrine transport(GO:0048241) epinephrine secretion(GO:0048242) |
| 0.2 |
2.0 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.2 |
2.0 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
| 0.2 |
0.7 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.2 |
0.7 |
GO:0046210 |
nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.2 |
1.2 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.2 |
2.5 |
GO:0015813 |
L-glutamate transport(GO:0015813) |
| 0.2 |
0.7 |
GO:0006598 |
polyamine catabolic process(GO:0006598) spermine catabolic process(GO:0046208) |
| 0.2 |
3.1 |
GO:0032106 |
positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
| 0.2 |
0.5 |
GO:1903071 |
positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.2 |
2.5 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.2 |
0.8 |
GO:0043928 |
exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.2 |
2.1 |
GO:2000785 |
regulation of vacuole organization(GO:0044088) regulation of autophagosome assembly(GO:2000785) |
| 0.2 |
1.1 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.2 |
0.3 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 0.2 |
0.6 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.2 |
1.5 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.2 |
0.6 |
GO:2000726 |
negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) negative regulation of cardiac muscle cell differentiation(GO:2000726) |
| 0.2 |
0.5 |
GO:0044791 |
modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.2 |
0.6 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.2 |
3.7 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.2 |
1.0 |
GO:0098838 |
reduced folate transmembrane transport(GO:0098838) |
| 0.2 |
2.2 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.2 |
0.8 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.2 |
0.5 |
GO:0010985 |
negative regulation of lipoprotein particle clearance(GO:0010985) |
| 0.2 |
0.6 |
GO:0048538 |
thymus development(GO:0048538) |
| 0.2 |
0.3 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.2 |
1.4 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.2 |
0.3 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.2 |
0.2 |
GO:0032988 |
ribonucleoprotein complex disassembly(GO:0032988) |
| 0.2 |
3.2 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.2 |
0.5 |
GO:0035356 |
negative regulation of mitochondrial membrane potential(GO:0010917) cellular triglyceride homeostasis(GO:0035356) |
| 0.2 |
0.6 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.2 |
0.5 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.2 |
0.8 |
GO:1901727 |
positive regulation of histone deacetylase activity(GO:1901727) |
| 0.2 |
0.2 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) |
| 0.2 |
0.3 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.2 |
0.5 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.2 |
1.2 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.2 |
1.2 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.2 |
0.6 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.1 |
1.0 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 |
2.4 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.1 |
0.7 |
GO:0006497 |
protein lipidation(GO:0006497) |
| 0.1 |
0.6 |
GO:0035814 |
negative regulation of renal sodium excretion(GO:0035814) |
| 0.1 |
0.4 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.1 |
0.6 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.1 |
0.3 |
GO:0072395 |
signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
| 0.1 |
3.9 |
GO:0045921 |
positive regulation of exocytosis(GO:0045921) |
| 0.1 |
2.3 |
GO:0035116 |
embryonic hindlimb morphogenesis(GO:0035116) |
| 0.1 |
0.4 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 |
0.7 |
GO:0018377 |
N-terminal protein myristoylation(GO:0006499) protein myristoylation(GO:0018377) |
| 0.1 |
0.6 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.1 |
0.4 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.1 |
1.0 |
GO:0050910 |
detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.1 |
2.8 |
GO:0033209 |
tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.1 |
0.6 |
GO:0015791 |
polyol transport(GO:0015791) |
| 0.1 |
0.1 |
GO:2000275 |
regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.1 |
1.0 |
GO:0007340 |
acrosome reaction(GO:0007340) |
| 0.1 |
0.7 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.1 |
1.3 |
GO:0042755 |
eating behavior(GO:0042755) |
| 0.1 |
0.4 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.1 |
0.7 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.1 |
0.8 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.1 |
0.4 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.1 |
0.1 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 0.1 |
6.5 |
GO:0006892 |
post-Golgi vesicle-mediated transport(GO:0006892) |
| 0.1 |
1.3 |
GO:0051693 |
actin filament capping(GO:0051693) |
| 0.1 |
0.6 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.1 |
0.6 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.1 |
5.2 |
GO:0007613 |
memory(GO:0007613) |
| 0.1 |
0.6 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.1 |
0.1 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.1 |
0.3 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.1 |
2.8 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.1 |
1.8 |
GO:0030811 |
regulation of glycolytic process(GO:0006110) regulation of nucleotide catabolic process(GO:0030811) |
| 0.1 |
0.9 |
GO:0042790 |
transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
| 0.1 |
0.1 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
| 0.1 |
0.6 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.1 |
2.3 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 |
1.0 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
| 0.1 |
0.4 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.1 |
1.0 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.1 |
1.7 |
GO:0035418 |
protein localization to synapse(GO:0035418) |
| 0.1 |
0.5 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 0.1 |
0.2 |
GO:0098528 |
skeletal muscle fiber differentiation(GO:0098528) |
| 0.1 |
0.5 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.1 |
0.2 |
GO:2001268 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.1 |
0.7 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 |
1.0 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
| 0.1 |
0.6 |
GO:0060426 |
lung vasculature development(GO:0060426) |
| 0.1 |
1.6 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
7.1 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.1 |
4.6 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.1 |
0.2 |
GO:0060594 |
mammary gland formation(GO:0060592) mammary gland specification(GO:0060594) |
| 0.1 |
2.2 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.1 |
0.5 |
GO:0045835 |
negative regulation of meiotic nuclear division(GO:0045835) |
| 0.1 |
4.9 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.1 |
0.5 |
GO:0050812 |
regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.1 |
0.1 |
GO:1904008 |
response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
| 0.1 |
0.5 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.1 |
0.7 |
GO:0035336 |
long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
| 0.1 |
1.0 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.1 |
0.1 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.1 |
0.3 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.1 |
3.4 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
| 0.1 |
0.7 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
0.3 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 0.1 |
0.8 |
GO:0060340 |
positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.1 |
2.1 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.1 |
1.1 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
| 0.1 |
1.8 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.1 |
0.5 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 0.1 |
0.7 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.1 |
1.6 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.1 |
0.5 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.1 |
0.2 |
GO:0060312 |
regulation of blood vessel remodeling(GO:0060312) |
| 0.1 |
1.2 |
GO:0000478 |
endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
| 0.1 |
0.6 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.1 |
2.3 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.1 |
0.8 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.1 |
0.9 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.1 |
1.0 |
GO:0046856 |
phospholipid dephosphorylation(GO:0046839) phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 |
0.8 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.1 |
0.3 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.1 |
0.6 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.1 |
0.3 |
GO:0033152 |
immunoglobulin V(D)J recombination(GO:0033152) |
| 0.1 |
1.3 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 0.1 |
0.4 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.1 |
0.6 |
GO:0043921 |
modulation by host of viral transcription(GO:0043921) modulation of transcription in other organism involved in symbiotic interaction(GO:0052312) modulation by host of symbiont transcription(GO:0052472) |
| 0.1 |
0.4 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.1 |
0.3 |
GO:0000393 |
spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.1 |
0.3 |
GO:0010891 |
negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.1 |
0.1 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.1 |
0.1 |
GO:0061620 |
glycolytic process through glucose-6-phosphate(GO:0061620) |
| 0.1 |
0.3 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 0.1 |
0.4 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 |
0.6 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.1 |
1.0 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.1 |
0.2 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.1 |
2.6 |
GO:0070059 |
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
| 0.1 |
0.3 |
GO:0090292 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.1 |
0.2 |
GO:0001963 |
synaptic transmission, dopaminergic(GO:0001963) |
| 0.1 |
1.3 |
GO:0071158 |
positive regulation of cell cycle arrest(GO:0071158) |
| 0.1 |
0.1 |
GO:0090239 |
regulation of histone H4 acetylation(GO:0090239) |
| 0.1 |
1.3 |
GO:2000279 |
negative regulation of DNA biosynthetic process(GO:2000279) |
| 0.1 |
1.3 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.1 |
0.2 |
GO:0045583 |
regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
| 0.1 |
0.5 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.1 |
0.4 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.1 |
0.9 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.1 |
1.2 |
GO:0031958 |
corticosteroid receptor signaling pathway(GO:0031958) |
| 0.1 |
0.7 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.1 |
0.7 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.1 |
0.2 |
GO:0008355 |
olfactory learning(GO:0008355) |
| 0.1 |
0.3 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.1 |
0.8 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.1 |
0.7 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 |
0.2 |
GO:0045448 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.1 |
3.5 |
GO:0030166 |
proteoglycan biosynthetic process(GO:0030166) |
| 0.1 |
0.2 |
GO:0034287 |
detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.1 |
0.4 |
GO:1904321 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 |
0.5 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.1 |
0.6 |
GO:1903960 |
negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) |
| 0.1 |
0.3 |
GO:0046016 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
| 0.1 |
0.3 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.1 |
2.8 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.1 |
5.2 |
GO:0006906 |
vesicle fusion(GO:0006906) |
| 0.1 |
0.3 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.1 |
0.6 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.1 |
0.6 |
GO:0043388 |
positive regulation of DNA binding(GO:0043388) |
| 0.1 |
0.5 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.1 |
0.8 |
GO:0032402 |
melanosome transport(GO:0032402) |
| 0.1 |
1.0 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 |
0.4 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.1 |
1.2 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.1 |
1.3 |
GO:0033120 |
positive regulation of RNA splicing(GO:0033120) |
| 0.1 |
7.4 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
| 0.1 |
0.4 |
GO:0038032 |
termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.1 |
2.3 |
GO:0048255 |
mRNA stabilization(GO:0048255) |
| 0.1 |
0.8 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.1 |
0.5 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.1 |
0.6 |
GO:0042516 |
regulation of tyrosine phosphorylation of Stat3 protein(GO:0042516) |
| 0.1 |
0.4 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 0.1 |
2.7 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.1 |
0.2 |
GO:0036112 |
medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.1 |
0.3 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.1 |
1.3 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.1 |
0.3 |
GO:0051350 |
negative regulation of cyclase activity(GO:0031280) negative regulation of lyase activity(GO:0051350) |
| 0.1 |
0.4 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.1 |
0.1 |
GO:0060013 |
righting reflex(GO:0060013) |
| 0.1 |
0.2 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 |
0.5 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.1 |
0.7 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.1 |
0.3 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.1 |
0.5 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.1 |
1.3 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.1 |
0.8 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.1 |
0.9 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.1 |
0.1 |
GO:1902260 |
negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
| 0.1 |
1.4 |
GO:0072661 |
protein targeting to plasma membrane(GO:0072661) |
| 0.1 |
0.7 |
GO:0018126 |
protein hydroxylation(GO:0018126) |
| 0.1 |
0.1 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.1 |
1.6 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.1 |
0.4 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.1 |
1.0 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.1 |
0.8 |
GO:0007041 |
lysosomal transport(GO:0007041) |
| 0.1 |
0.2 |
GO:0045072 |
regulation of interferon-gamma biosynthetic process(GO:0045072) positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.1 |
0.8 |
GO:1900153 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.1 |
3.0 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.1 |
0.5 |
GO:0034694 |
response to prostaglandin(GO:0034694) response to prostaglandin E(GO:0034695) |
| 0.1 |
2.3 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.1 |
3.3 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.1 |
0.7 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.1 |
0.4 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.1 |
0.1 |
GO:1901660 |
calcium ion export(GO:1901660) |
| 0.1 |
0.2 |
GO:0007128 |
meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
| 0.1 |
0.2 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.1 |
2.1 |
GO:0042771 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.1 |
0.1 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.1 |
0.1 |
GO:0090174 |
organelle membrane fusion(GO:0090174) |
| 0.1 |
0.9 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.1 |
0.4 |
GO:0061050 |
regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
| 0.1 |
0.6 |
GO:2000404 |
regulation of T cell migration(GO:2000404) |
| 0.1 |
0.5 |
GO:1900364 |
negative regulation of mRNA 3'-end processing(GO:0031441) negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.1 |
0.4 |
GO:0010996 |
response to auditory stimulus(GO:0010996) |
| 0.1 |
0.3 |
GO:0010955 |
negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
| 0.1 |
0.7 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.1 |
0.6 |
GO:0035518 |
histone H2A monoubiquitination(GO:0035518) |
| 0.1 |
6.1 |
GO:0000209 |
protein polyubiquitination(GO:0000209) |
| 0.1 |
1.1 |
GO:0021799 |
cerebral cortex radially oriented cell migration(GO:0021799) |
| 0.1 |
0.2 |
GO:0050927 |
positive regulation of positive chemotaxis(GO:0050927) |
| 0.1 |
0.3 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.1 |
0.3 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.1 |
0.1 |
GO:0048711 |
positive regulation of astrocyte differentiation(GO:0048711) |
| 0.1 |
0.2 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.1 |
0.3 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.1 |
1.1 |
GO:0006487 |
protein N-linked glycosylation(GO:0006487) |
| 0.1 |
1.0 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 |
0.2 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.1 |
0.5 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 |
0.1 |
GO:0046716 |
muscle cell cellular homeostasis(GO:0046716) |
| 0.1 |
0.8 |
GO:0070200 |
establishment of protein localization to telomere(GO:0070200) |
| 0.0 |
0.1 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 0.0 |
0.2 |
GO:0051531 |
NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
| 0.0 |
0.4 |
GO:0009650 |
UV protection(GO:0009650) |
| 0.0 |
0.1 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.0 |
1.9 |
GO:0010951 |
negative regulation of endopeptidase activity(GO:0010951) |
| 0.0 |
0.1 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.0 |
0.1 |
GO:0090141 |
positive regulation of mitochondrial fission(GO:0090141) |
| 0.0 |
0.6 |
GO:0008214 |
protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
| 0.0 |
0.2 |
GO:0031509 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.0 |
0.3 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.0 |
0.7 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) |
| 0.0 |
0.2 |
GO:0043137 |
DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
| 0.0 |
0.4 |
GO:0043029 |
T cell homeostasis(GO:0043029) |
| 0.0 |
0.2 |
GO:1902035 |
positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.0 |
0.5 |
GO:0002385 |
organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
| 0.0 |
1.5 |
GO:0006406 |
mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.0 |
0.2 |
GO:0090201 |
negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.0 |
0.3 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.0 |
0.4 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.0 |
0.1 |
GO:0045683 |
negative regulation of epidermis development(GO:0045683) |
| 0.0 |
0.8 |
GO:0009268 |
response to pH(GO:0009268) |
| 0.0 |
2.6 |
GO:0006364 |
rRNA processing(GO:0006364) |
| 0.0 |
0.4 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.0 |
0.2 |
GO:0006221 |
pyrimidine nucleotide biosynthetic process(GO:0006221) |
| 0.0 |
0.1 |
GO:0006244 |
pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.0 |
0.1 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.0 |
0.1 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.0 |
0.1 |
GO:1902882 |
regulation of response to oxidative stress(GO:1902882) |
| 0.0 |
1.6 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.0 |
0.1 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.0 |
0.3 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.0 |
0.2 |
GO:0015879 |
carnitine transport(GO:0015879) |
| 0.0 |
0.1 |
GO:0045109 |
intermediate filament organization(GO:0045109) |
| 0.0 |
2.0 |
GO:0007030 |
Golgi organization(GO:0007030) |
| 0.0 |
0.1 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.0 |
0.1 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.0 |
0.3 |
GO:0030325 |
adrenal gland development(GO:0030325) |
| 0.0 |
0.1 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.0 |
0.1 |
GO:0000279 |
mitotic M phase(GO:0000087) M phase(GO:0000279) mitotic cell cycle phase(GO:0098763) |
| 0.0 |
0.3 |
GO:0007193 |
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
| 0.0 |
0.1 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.0 |
0.3 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.0 |
0.2 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.0 |
0.3 |
GO:0036159 |
inner dynein arm assembly(GO:0036159) |
| 0.0 |
0.4 |
GO:0032933 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.0 |
0.2 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.0 |
0.1 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.0 |
0.2 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.0 |
0.1 |
GO:0015867 |
ATP transport(GO:0015867) |
| 0.0 |
0.2 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.0 |
0.1 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.0 |
0.2 |
GO:0009651 |
response to salt stress(GO:0009651) |
| 0.0 |
0.1 |
GO:0009067 |
aspartate family amino acid biosynthetic process(GO:0009067) |
| 0.0 |
0.2 |
GO:0044253 |
positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
| 0.0 |
0.2 |
GO:0046621 |
negative regulation of organ growth(GO:0046621) |
| 0.0 |
0.9 |
GO:0008543 |
fibroblast growth factor receptor signaling pathway(GO:0008543) |
| 0.0 |
0.3 |
GO:0043486 |
histone exchange(GO:0043486) |
| 0.0 |
0.2 |
GO:0060149 |
negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by RNA(GO:0060967) |
| 0.0 |
0.2 |
GO:0009143 |
nucleoside triphosphate catabolic process(GO:0009143) |
| 0.0 |
0.2 |
GO:0006206 |
pyrimidine nucleobase metabolic process(GO:0006206) |
| 0.0 |
0.2 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.0 |
0.1 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.0 |
0.0 |
GO:0000414 |
regulation of histone H3-K36 methylation(GO:0000414) |
| 0.0 |
0.5 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.0 |
0.1 |
GO:0006662 |
glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) ether lipid metabolic process(GO:0046485) |
| 0.0 |
0.2 |
GO:0006828 |
manganese ion transport(GO:0006828) |
| 0.0 |
0.1 |
GO:0061032 |
visceral serous pericardium development(GO:0061032) |
| 0.0 |
0.1 |
GO:2000059 |
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.0 |
0.1 |
GO:0010614 |
negative regulation of cardiac muscle hypertrophy(GO:0010614) |
| 0.0 |
0.0 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
| 0.0 |
0.1 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.0 |
0.1 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.0 |
0.7 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.0 |
0.1 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.0 |
0.4 |
GO:0051101 |
regulation of DNA binding(GO:0051101) |
| 0.0 |
0.0 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.0 |
0.1 |
GO:0002446 |
neutrophil mediated immunity(GO:0002446) |
| 0.0 |
1.0 |
GO:0030308 |
negative regulation of cell growth(GO:0030308) |
| 0.0 |
0.1 |
GO:0003148 |
outflow tract septum morphogenesis(GO:0003148) |
| 0.0 |
0.2 |
GO:0060914 |
heart formation(GO:0060914) |
| 0.0 |
0.0 |
GO:0015684 |
ferrous iron transport(GO:0015684) |
| 0.0 |
0.0 |
GO:0046006 |
regulation of activated T cell proliferation(GO:0046006) |
| 0.0 |
0.1 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.0 |
0.0 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.0 |
0.1 |
GO:0009081 |
branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 |
0.0 |
GO:1904666 |
regulation of ubiquitin protein ligase activity(GO:1904666) |
